Jia-Xian Liao

This study proposed a noninvasive blood glucose estimation system based on dual-wavelength photoplethysmography (PPG) and bioelectrical impedance measuring technology that can avoid the discomfort created by conventional invasive blood glucose measurement methods while accurately estimating blood glucose. The measured PPG signals are converted into mean, variance, skewness, kurtosis, standard deviation, and information entropy. The data obtained by bioelectrical impedance measuring consist of the real part, imaginary part, phase, and amplitude size of 11 types of frequencies, which are converted into features through principal component analyses. After combining the input of seven physiological features, the blood glucose value is finally obtained as the input of the back-propagation neural network (BPNN). To confirm the robustness of the system operation, this study collected data from 40 volunteers and established a database. From the experimental results, the system has a mean squared error of 40.736, a root mean squared error of 6.3824, a mean absolute error of 5.0896, a mean absolute relative difference of 4.4321%, and a coefficient of determination (R Squared, R²) of 0.997, all of which fall within the clinically accurate region A in the Clarke error grid analyses.

This paper presents a wearable device, fitted on the waist of a participant that recognizes six activities of daily living (walking, walking upstairs, walking downstairs, sitting, standing, and laying) through a deep-learning algorithm, human activity recognition (HAR). The wearable device comprises a single-board computer (SBC) and six-axis sensors. The deep-learning algorithm employs three parallel convolutional neural networks for local feature extraction and for subsequent concatenation to establish feature fusion models of varying kernel size. By using kernels of different sizes, relevant local features of varying lengths were identified, thereby increasing the accuracy of human activity recognition. Regarding experimental data, the database of University of California, Irvine (UCI) and self-recorded data were used separately. The self-recorded data were obtained by having 21 participants wear the device on their waist and perform six common activities in the laboratory. These data were used to verify the proposed deep-learning algorithm on the performance of the wearable device. The accuracy of these six activities in the UCI dataset and in the self-recorded data were 97.49% and 96.27%, respectively. The accuracies in tenfold cross-validation were 99.56% and 97.46%, respectively. The experimental results have successfully verified the proposed convolutional neural network (CNN) architecture, which can be used in rehabilitation assessment for people unable to exercise vigorously.

In this paper, we propose a continuous physiological parameter estimation model based on a deep learning network for photoplethysmography (PPG) sensor signals. Signals of 8-s duration were incorporated into the proposed model in this study for frequent estimation of the systolic blood pressure (BP), diastolic BP, heart rate (HR), and mean arterial pressure of the human body; this facilitated early identification and monitoring of physiological conditions and thus reduced the risk of cardiovascular disease. The proposed model was designed using a convolutional neural network (CNN) and long short-term memory (LSTM) network. This model was trained and validated using the large-scale Multiparameter Intelligent Monitoring in Intensive Care database. The CNN was used to extract features from PPG signals automatically. This automatic extraction replaced the conventional manual feature extraction process. Features with time-series were then analyzed using the LSTM network to estimate physiological parameters. Subsequently, ten-fold cross-validation was conducted to reveal the mean absolute errors ± standard deviations of participants’ systolic BP, diastolic BP, HR, and mean arterial pressure to be 2.54 ± 3.88, 1.59 ± 2.45, 1.62 ± 2.55, and 1.59 ± 2.34 mmHg, respectively. These values meet the standards established by the Association for the Advancement of Medical Instrumentation and the British Hypertension Society. The proposed method facilitates the accurate, continuous monitoring of the BP and HR.